IRVINE, Calif.--Allergan, Inc., based here, has named F. Michael Ball as president, effective February 1, 2006. Additionally, Allergan announced the appointment of Raymond Diradoorian to executive vice president, global technical operations. David E.I. Pyott will maintain his position as Allergan’s chief executive officer and chairman of the board.

Ball has served as Allergan’s executive vice president and president, pharmaceuticals since 2003. In this role, he was instrumental in the reorganization and management of Allergan’s global commercial operations, according to a company statement. Ball joined Allergan in 1995 and has held positions of increasing responsibility, including corporate vice president and president North America. Prior to joining Allergan, he was at Syntex Laboratories USA, where he held various senior level positions in the marketing, sales and managed care functions.

Diradoorian joined Allergan in 1981. Over the past 25 years he has managed the company’s global manufacturing, engineering and operations areas. In 2005, Diradoorian was appointed as Allergan’s senior vice president, global technical operations, where he was responsible for the global network of manufacturing plants, quality assurance, environmental health and safety and various other operational functions.